FDA approves first gene-editing treatments for human illness
In landmark decisions, the Food and Drug Administration approved two gene-editing treatments for sickle cell disease. The approvals offers new hope for patients and signal a new era in medicine.
Read more on NPR
No comments:
Post a Comment